Voice Biomarkers Predictive of Depression and Anxiety

CompletedOBSERVATIONAL
Enrollment

19,533

Participants

Timeline

Start Date

September 14, 2021

Primary Completion Date

September 11, 2022

Study Completion Date

September 11, 2022

Conditions
Depression, AnxietyHealthyMental Health Wellness 1
Interventions
DIAGNOSTIC_TEST

Patient Health Questionnaire-9

The Patient Health Questionnaire-9 is a nine question self-administered examination in which the patient indicates how often they have experienced different feelings and sensations in the past two weeks. The Patient Health Questionnaire-9 is scored from 0 to 27 where higher scores are associated with more severe depression.

DIAGNOSTIC_TEST

Generalized Anxiety Disorder-7

The Generalized Anxiety Disorder-7 is a seven question self-administered examination in which the patient indicates how often they have experienced different feelings and sensations in the past two weeks. The Generalized Anxiety Disorder-7 is scored from 0 to 21 where higher scores are associated with more severe anxiety.

DIAGNOSTIC_TEST

Hamilton Depression Rating Scale

The Hamilton Depression Rating Scale is administered by a mental health profession and includes twenty-one questions asking about how the participant has been feeling in the past week. The Hamilton Depression Rating Scale is scored from 0 to 45 where higher scores are associated with more severe depression.

DIAGNOSTIC_TEST

Hamilton Anxiety Rating Scale

The Hamilton Anxiety Rating Scale is administered by a mental health profession and includes fourteen questions asking about how the participant has been feeling in the past week. The Hamilton Anxiety Rating Scale is scored from 0 to 56 where higher scores are associated with more severe anxiety.

Trial Locations (1)

94705

Kintsugi Mindful Wellness, Inc., Berkeley

All Listed Sponsors
lead

Kintsugi Mindful Wellness, Inc.

INDUSTRY

NCT05455905 - Voice Biomarkers Predictive of Depression and Anxiety | Biotech Hunter | Biotech Hunter